A buyout of both SUPG and MOGN? Mogn probable will never be this cheap again -if aloxi and Dacogen hit there numbers. Supg is looking like it's future has improved. Why not a third party scoop both up?
I believe this could work....for about 2B some bio firm could scoop up both companies. With Mogn you get 3 approved drugs +another drug just months away from approval and a very strong pipeline. With SUPG 50M + royalities and 30% ww sales of dacogen(which could be 200M+ a year)+ there current pipeline. I just think this could fit nicely somewhere. Once J&J see results on Dacogen think they would not want to share it. This could be one reason to drag there feet on EU approval for dacogen?